CLINICAL_TRIALS
trial_result
· 2024-01-05
Clinical Trial Update: Silverlon to Reduce Radiation Dermatitis [Phase 1]
Summary
Phase 1 clinical trial evaluating Silverlon to reduce radiation dermatitis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Radiation Dermatitis | Phase 1 | Status: COMPLETED | Results posted: 2024-01-05